Evidence map›Paper›PMID 35693200›Full record

ArticlePrecision clinical medicine2018

Evidence-based medicine and precision medicine: Complementary approaches to clinical decision-making.

Ngai Chow, Lucas Gallo, Jason W Busse

Open access · diamondAbstract read
In one paragraph

Article in Precision clinical medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 40 citations in OpenAlex.

  1. Exploring interdisciplinary perspectives on the implementation ofJournal of Alzheimer's disease : JAD · 2025
    Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Data Consult Service: Can we use observational data to address immediate clinical needs?Journal of the American Medical Informatics Association : JAMIA · 2021
    Article
  10. Review
  11. Precision Medicine: A New Paradigm in Therapeutics.International journal of preventive medicine · 2021
    Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Data-driven clinical decision processes: it's time.Journal of translational medicine · 2019
    Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Ngai ChowDepartment of Health Research Methods, Evidence and Impact, McMaster University, HSC-2C, 1280 Main St. West, Hamilton, Ontario, Canada.
Lucas GalloDepartment of Medicine, McMaster University, 4V33, 1280 Main St. West, Hamilton, Ontario, Canada.
Jason W BusseDepartment of Health Research Methods, Evidence and Impact, McMaster University, HSC-2C, 1280 Main St. West, Hamilton, Ontario, Canada.ORCID 0000-0002-0178-8712
Impact · CAMcMaster University · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Evidence-based medicine is widely promoted for decision-making in health care and is associated with improved patient outcomes. Critics have suggested that evidence-based medicine focuses primarily on groups of patients rather than individuals, but often fail to consider subgroup analyses, N-of-1 trials, and the incorporation of patient values and preferences. Precision medicine has been promoted as an approach to individualize diagnosis and treatment of diseases through genetic, biomarker, phenotypic, and psychosocial characteristics. However, there are often high costs associated with personalized medicine, and high-quality evidence is lacking for effectiveness in many applications. For the potential of personalized medicine to be realized, it must adhere to the principles of evidence-based medicine: (1) evidence in isolation is not sufficient to make clinical decisions-patient's values and preferences as well as resource implications must be considered, and (2) there is a hierarchy of evidence to guide clinical decision-making and studies at lower risk of bias are likely to provide more trustworthy findings.

Indexed as

decision-makingevidence-based medicineprecision medicine

Identifiers

PMID35693200
PMCPMC8985809
OpenAlexW2887183444

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.